Abstract:Objectives: To describe the clinical and urodynamic features of patients with voiding dysfunction secondary to schistosomal myelopathy. Schistosomiasis mansoni is an endemic fluke infection in South America, the Caribbean, and Africa. In the United States and Europe, people may be infected mainly through travel to endemic areas and immigration of infected individuals. Clinical involvement of the spinal cord is a well-recognized complication of the disease. The typical manifestations are those of an acute transverse myelitis, with sudden onset of lower extremity neuropathy associated with bladder and bowel dysfunction. Methods: We reviewed the records and urodynamic studies of 14 consecutive patients (10 men and 4 women, age range 23 to 49 years) with schistosomal myelopathy confirmed by cerebrospinal fluid serology for S. mansoni, who were referred for evaluation of voiding dysfunction during a 2-year period. At the time of the urologic evaluation, 9 patients had chronic neurologic and urinary symptoms and 5 had recent onset of acute symptoms. The voiding function history, urologic complications, and outcomes after therapy for schistosomiasis were reviewed. Results: Of the patients with acute disease (5 patients), the urologic symptoms included urinary retention (3 patients) and incontinence (2 patients). Three of them had concurrent lower back pain and lower limb neurologic deficits. Urodynamic studies were performed in 3 patients and revealed bladder areflexia in 2 patients and detrusor hyperreflexia with external sphincter dyssynergia in 1 patient. The patients were started on clean intermittent catheterization and received praziquantel and corticosteroids. Three patients had complete resolution of their symptoms, one recovered normal voiding function but the neurologic deficits persisted, and one had no clinical improvement. All patients with chronic schistosomal myelopathy presented with lower limb neurologic deficits of varying degrees and urinary symptoms, including difficulty emptying the bladder (7 patients), urinary incontinence (6 patients), and urgency and frequency (2 patients). Laboratory and radiographic evaluation of patients with chronic disease revealed urinary tract infection in 5 patients, hydronephrosis in 2 patients, and bladder calculi in 2 patients. Urologic management consisted of antibiotics, clean intermittent catheterization, anticholinergic medication, and stone removal, as appropriate. In 1 patient, conservative treatment failed and that patient required ileocystoplasty. Conclusions: Schistosomal myelopathy is a potential cause of severe voiding dysfunction secondary to spinal cord disease. A high index of suspicion is paramount because early medical intervention can abort the progression of neurologic deterioration.

Insight into SLC9A3 deficiency-mediated micturition dysfunction caused by electrolyte imbalance

Myogenic bladder defects in mouse models of human oculodentodigital dysplasia.

Mitochondrial SLC3A1 regulates sexual dimorphism in cystinuria

Reduced surface pH and upregulated AE2 anion exchange in SLC26A3-deleted polarized intestinal epithelial cells

SLC41A1 knockout mice display normal magnesium homeostasis

Slc7a9 knockout mouse is a good cystinuria model for antilithiasic pharmacological studies

MP11-11 ACTIVATION OF NFKB-JMJD3 SIGNALING PROMOTES BLADDER FIBROSIS VIA BOOSTING BLADDER SMOOTH MUSCLE CELL PROLIFERATION AND COLLAGEN ACCUMULATION

Genetic and Biological Effects of SLC12A3, a Sodium-Chloride Cotransporter, in Gitelman Syndrome and Diabetic Kidney Disease

Extracellular Cl − Regulates Human SO 4 2− /anion Exchanger SLC26A1 by Altering Ph Sensitivity of Anion Transport

Impact of intravascular hemolysis on functional and molecular alterations in the urinary bladder: implications for an overactive bladder in sickle cell disease

Alzheimer's disease amyloidogenesis is linked to altered lower urinary tract physiology

Impairment in renal medulla development underlies salt wasting in Clc-k2 channel deficiency

Urinary Sodium Wasting and Disrupted Collecting Duct Function in Mice with dRTA-Causing SLC4A1 Mutations

Urological manifestations of chronic schistosomal myeloradiculopathy

Genetic Contributions to Lower Urinary Tract Dysfunction

Clinical Characteristics and In Silico Analysis of Cystinuria Caused by a Novel SLC3A1 Mutation

Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice

Schistosomal myelopathy: urologic manifestations and urodynamic findings

Urea and Urine Concentrating Ability in Mice Lacking AQP1 and AQP3

Urine Stasis Predisposes to Urinary Tract Infection by an Opportunistic Uropathogen in the Megabladder (Mgb) Mouse

Reduced sodium/proton exchanger NHE3 activity causes congenital sodium diarrhea